In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature
- PMID: 30551359
- DOI: 10.1016/j.biopha.2018.10.130
In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature
Abstract
Quercetin, a typical flavonoid, possesses diverse biochemical and physiological actions, including antiplatelet, estrogenic, and anti-inflammatory properties. This review mainly centers on recent ten years findings with respect to intervening diabetes and its complications with the well-known flavonoid quercetin. After a short introduction of quercetin, major in vitro and in vivo findings are summarized showing that quercetin is a promising molecule for the treatment of these diseases. Finally, we contemplate future development and application prospects of quercetin. Despite the wealth of in animal research results suggesting the anti-diabetic and its complications potential of quercetin, its efficacy in diabetic human subjects is yet to be explored. The problem may become an important direction in the future research.
Keywords: Diabetes; Diabetic complications; In vitro and in vivo evidence; Quercetin.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Hallmarks of Quercetin Benefits as a Functional Supplementary in the Management of Diabetes Mellitus-Related Maladies: From Basic to Clinical Applications.Curr Drug Metab. 2024;25(9):653-669. doi: 10.2174/0113892002339410250108031621. Curr Drug Metab. 2024. PMID: 39878112 Review.
-
Quercetin: a potential drug to reverse multidrug resistance.Life Sci. 2010 Sep 11;87(11-12):333-8. doi: 10.1016/j.lfs.2010.07.004. Epub 2010 Jul 15. Life Sci. 2010. PMID: 20637779 Review.
-
Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.Mol Cell Endocrinol. 2017 Sep 5;452:44-56. doi: 10.1016/j.mce.2017.05.011. Epub 2017 May 10. Mol Cell Endocrinol. 2017. PMID: 28501572
-
Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review.Biomed Pharmacother. 2017 Jul;91:31-42. doi: 10.1016/j.biopha.2017.04.057. Epub 2017 Apr 23. Biomed Pharmacother. 2017. PMID: 28445831 Review.
-
A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications.Biomed Pharmacother. 2020 May;125:109767. doi: 10.1016/j.biopha.2019.109767. Epub 2020 Feb 12. Biomed Pharmacother. 2020. PMID: 32058210 Review.
Cited by
-
An Updated Systematic Review of Vaccinium myrtillus Leaves: Phytochemistry and Pharmacology.Pharmaceutics. 2022 Dec 21;15(1):16. doi: 10.3390/pharmaceutics15010016. Pharmaceutics. 2022. PMID: 36678645 Free PMC article. Review.
-
Health Benefits of Quercetin in Age-Related Diseases.Molecules. 2022 Apr 13;27(8):2498. doi: 10.3390/molecules27082498. Molecules. 2022. PMID: 35458696 Free PMC article. Review.
-
A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence.Nutrients. 2019 Apr 13;11(4):841. doi: 10.3390/nu11040841. Nutrients. 2019. PMID: 31013914 Free PMC article. Review.
-
Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats.Ren Fail. 2024 Dec;46(1):2327495. doi: 10.1080/0886022X.2024.2327495. Epub 2024 Mar 11. Ren Fail. 2024. PMID: 38465879 Free PMC article.
-
A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.Evid Based Complement Alternat Med. 2020 Oct 31;2020:6754761. doi: 10.1155/2020/6754761. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33178322 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical